Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Guselkumab & Ulcerative colitis (UC), FDA approval covers guselkumab for the treatment of adults with moderately to severely active ulcerative colitis. Subsequent label expansions are for intravenous (IV) and subcutaneous (SC) induction/maintenance regimens (1)
The EMA/EC approval covers guselkumab for the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response, or intolerance to conventional therapy or a biologic treatment initially based on intravenous (IV) …